Talk to a representative to learn how VMS+ can be used to help patients who have developed acute heart conditions. Learn how VMS+ aids in diagnosis and treatment by providing more accurate volumes and ejection fractions.
HOW CAN VMS+ HELP?
THERE ARE MANY BENEFITS
Obtain a 3D model of the heart and accurate, reproducible volume and ejection fraction quantification. Generate measurements that are equivalent to MRI in less than 5 minutes. Thus, allowing the clinician to monitor a patient’s heart more closely and provide early treatment during a viral pandemic when MRI is not readily available.
POINT OF CARE
The VMS+ system can be easily connected to any 2D cardiac ultrasound and be used in the ICU, emergency room and long term care homes. Moreover, the system can be easily disinfected with cleaning agents commonly used by hospitals and thus aiding in infection control.
The VMS+ software can be installed on any personal workstation and cardiac quantification can be done remotely at any time following an echo. Also, a clinician can easily share the 3D model of the patient's heart and the corresponding cardiac quantification with any physician via PACS.
Driven by a step-by-step guided workflow that enables clinicians to perform acquisition and analysis with minimal training.
Scientific Journal Review
Global evaluation of echocardiography in patients with COVID-19
European Heart Journal - Cardiovascular Imaging, jeaa178, https://doi.org/10.1093/ehjci/jeaa178, Published: 18 June 2020
Aims to describe the cardiac abnormalities in patients with COVID-19 and identify the characteristics of patients who would benefit most from echocardiography.
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases,JAMA Cardiol. Published online July 27, 2020. doi:10.1001/jamacardio.2020.3551
COVID-19 and Heart Failure With Preserved Ejection Fraction
AMA. Published online September 30, 2020. doi:10.1001/jama.2020.17445
Reports an echocardiographic study of 100 patients with COVID-19 found the most common abnormalities were right ventricular dilation (39%)